Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» NT-814
NT-814
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Fierce Biotech
Bayer
KaNDy Therapeutics
M&A
Women's Health
menopause
hot flashes
NT-814
Flag link:
Women’s health firm KaNDy raises $32M for menopause study
Women’s health firm KaNDy raises $32M for menopause study
Fierce Biotech
KaNDy Therapeutics
clinical trials
menopause
NT-814
Flag link:
